title: Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.
abstract: Viruses are known to use virally encoded envelope proteins for cell attachment, which is the very first step of virus infection. In the present study, we have obtained substantial evidence demonstrating that hepatitis C virus (HCV) uses the cellular protein apolipoprotein E (apoE) for its attachment to cells. An apoE-specific monoclonal antibody was able to efficiently block HCV attachment to the hepatoma cell line Huh-7.5 as well as primary human hepatocytes. After HCV bound to cells, however, anti-apoE antibody was unable to inhibit virus infection. Conversely, the HCV E2-specific monoclonal antibody CBH5 did not affect HCV attachment but potently inhibited HCV entry. Similarly, small interfering RNA-mediated knockdown of the key HCV receptor/coreceptor molecules CD81, claudin-1, low-density lipoprotein receptor (LDLr), occludin, and SR-BI did not affect HCV attachment but efficiently suppressed HCV infection, suggesting their important roles in HCV infection at postattachment steps. Strikingly, removal of heparan sulfate from the cell surface by treatment with heparinase blocked HCV attachment. Likewise, substitutions of the positively charged amino acids with neutral or negatively charged residues in the receptor-binding region of apoE resulted in a reduction of apoE-mediating HCV infection. More importantly, mutations of the arginine and lysine to alanine or glutamic acid in the receptor-binding region ablated the heparin-binding activity of apoE, as determined by an in vitro heparin pulldown assay. HCV attachment could also be inhibited by a synthetic peptide derived from the apoE receptor-binding region. Collectively, these findings demonstrate that apoE mediates HCV attachment through specific interactions with cell surface heparan sulfate.
authors.affiliation: Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
authors.forename: Jieyun
authors.initials: J
authors.lastname: Jiang
authors.forename: Wei
authors.initials: W
authors.lastname: Cun
authors.forename: Xianfang
authors.initials: X
authors.lastname: Wu
authors.forename: Qing
authors.initials: Q
authors.lastname: Shi
authors.forename: Hengli
authors.initials: H
authors.lastname: Tang
authors.forename: Guangxiang
authors.initials: G
authors.lastname: Luo
mesh_terms: D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D055785:Gene Knockdown Techniques; D016174:Hepacivirus / Q000502:physiology*; D006497:Heparan Sulfate / Q000378:metabolism*; D022781:Hepatocytes / Q000821:virology*; D006801:Humans; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D017354:Point Mutation; D011485:Protein Binding; D011991:Receptors, Virus / Q000037:antagonists & inhibitors / Q000378:metabolism; D053585:Virus Attachment
chemical_list: D001057:Apolipoproteins E; D006497:Heparan Sulfate; D050505:Mutant Proteins; D011991:Receptors, Virus